Which assessment finding could indicate a deterioration in a patient with fibrocystic breast disease?

The presence of new lumps or masses in a patient with fibrocystic breast disease could indicate a deterioration in their condition. Fibrocystic breast disease generally involves the development of lumpiness and tenderness in the breasts due to hormonal changes, and while some lumps may be benign and part of the condition itself, the emergence of new or differing lumps or masses can be concerning. This change can suggest the possibility of an underlying issue that requires further evaluation, such as an increase in abnormal cell activity or even the development of a more serious condition, like breast cancer.

Regular monitoring of breast patterns and changes is crucial for patients with fibrocystic breast disease, as it is pivotal to discern normal fluctuations in breast tissue from potentially dangerous developments. Other symptoms, such as an increase in breast sensitivity or variations in discharge, may be common and not necessarily indicative of deterioration. Therefore, the identification of new lumps or masses warrants prompt clinical attention.